Statins are drugs that reduce cholesterol and prevent the risk of cardiovascular disease. But a new study found that statins may not protect older adults against diseases.

TOP INSIGHT
For older adults, treatment recommendations should be personalized to prevent the risk of cardiovascular disease because statin may not prevent the risk.
The authors used an analytical sample that included 2,867 adults with hypertension but without baseline atherosclerotic cardiovascular disease (plaque build-up in the arteries). Of the 2,867 adults, 1,467 were in the pravastatin sodium group (40 mg per day) and 1,400 received usual care from their primary care physician to lower cholesterol.
The authors report no benefit of pravastatin for the main outcome of all-cause mortality or secondary outcomes of coronary heart disease events and cause-specific mortality. More deaths occurred in the pravastatin group than in the usual care group (141 vs. 130) among adults 65 to 74 and among adults 75 and older (92 vs. 65).
There were 76 CHD events in the pravastatin group compared with 89 in the usual care group among adults 65 to 74 and 31 CHD events compared with 39 among adults 75 and older, according to the results. Stroke, heart failure, and cancer rates were similar in the two treatment groups for both age groups.
Authors note limitations of the current study, which include its design as a post hoc secondary analysis of a trial of a subgroup of patients.
The findings of the study is published in JAMA Internal Medicine.
MEDINDIA




Email









